113 In-depth proteomic characterisation of different aetiologies of cardiomyopathy. (4th June 2021)

• Record Type: Journal Article
• Authors: Tonry, Claire; Collier, Patrick; Moravec, Christine; Ledwidge, Mark; McDonald, Ken; Collins, Ben
• Is Part Of: Heart. Volume 107(2021)Supplement 1
• Page Start: A86
• Page End: A87
• Publication Date: 2021-06-04
• Subjects: heart failure -- biomarkers -- proteomics; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2021-BCS.112
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Introduction: The purpose of this study was to gain greater understanding of the pathogenesis of hypertrophic obstructive cardiomyopathy (HOCM), dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ISCM). These conditions lead to heart failure (HF) and the prognosis for HF differs based on the underlying aetiology. Cardiac tissue represents a challenging sample from the proteomics perspective due to the dominant signal from of a small number of high abundance proteins. Thus, a diaPASEF [1] workflow was applied in order to achieve deep quantitative coverage of cardiac tissue from HOCM (n=12), DCM (n=9), ISCM (n=9) and age/sex matched controls (NF, n=9). RNA-seq analysis has already been performed on these samples. Methods: Unbiased, deep proteomic analysis of individual samples was performed using the diaPASEF workflow on a timsTOF Pro mass spectrometer. Analysis of high pH-reversed phase fractionated sample pools was performed in ddaPASEF mode to generate spectral library data. Raw data files were processed through Spectronaut 14 software for spectral library building, protein identification and quantification. Differentially expressed proteins were identified based on an observed fold change of ≥ 1.5 or ≤-1.5 and q-value ≤ 0.005. Pathway analysis was performed using Ingenuity Pathway Analysis (IPA) software. Results and Conclusions/Implications: Label-free MS analysis led to over 4, 000 protein identifications, with 3, 484 proteins commonly identified across all patient samples. Over 1, 000 significantly differentially expressed protein candidates were identified for comparisons between NF and DCM, HOCM or ISCM. DCM-specific protein changes were strongly associated with glutamine biosynthesis, HOCM-specific protein changes were strongly associated with LXR/RXR Activation, while ISCM-specific protein changes were most associated with tryptophan degradation pathways. DCM vs NF, ISCM vs NF and HOCM v NF had shared differentially expressed proteins that were also significantly altered at gene level (n=106). Canonical pathway analysis revealed that Choline Degradation and Lysine Degradation pathways were most strongly associated with these candidates. Expression changes for some of the top over- and under-expressed HF candidates were validated in an independent replicate dataset (PXD008934) [2]. This represents one of the largest and deepest proteomic datasets for myocardial tissue reported to date. The dataset, which compliments existing transcriptomic data for these samples, has highlighted a number of significant proteins associated with different underlying aetiologies of HF. Prognosis for HF differs depending on the aetiology from which it arises. Hence, the dataset here will help in further understanding the pathogenesis of the disease, leading towards more personalised treatment. Conflict of Interest: N/A